FMR LLC bought 116,000 shares of CONSUN PHARMA on the SEHK open market at an average of HKD 14.4242 per share on September 24, 2026, involving about HKD 1.67 million. This is an on-exchange active trade, i.e. a direct dealing in the secondary market.
Prior to the acquisition, FMR LLC's long position in CONSUN PHARMA was 75.66 million shares, representing 8.99%; following the acquisition, the holding changed to 75.77 million shares, with the long position ratio rising to 9.0%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.